SPOTLIGHT: Cancer drug flunks Phase III
This is a discussion on SPOTLIGHT: Cancer drug flunks Phase III within the Biotechnology News forum, part of the Industry News and Updates category; BioNumerik Pharmaceuticals and ASKA Pharmaceutical said that a late-stage trial of Tavocept failed to produce a statistically significant response ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
03-19-2008, 08:08 AM
|
|||
|
|||
SPOTLIGHT: Cancer drug flunks Phase III
BioNumerik Pharmaceuticals and ASKA Pharmaceutical said that a late-stage trial of Tavocept failed to produce a statistically significant response in patients with advanced non-small cell lung Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Pfizer halts Phase III cancer trial on poor results | industry_news | Biotechnology News | 0 | 04-02-2008 01:39 PM |
| Wyeth, Progenics drug flunks Phase III trial | industry_news | Biotechnology News | 0 | 03-19-2008 08:08 AM |
| Wyeth, Progenics drug flunks trial | industry_news | Biotechnology News | 0 | 03-12-2008 12:40 PM |
| Phase III data sinks Keryx's diabetes drug | industry_news | Biotechnology News | 0 | 03-11-2008 01:26 PM |
© 2008 DrugManagementForum™ powered by |
 |